This compound is primarily used in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs targeting central nervous system disorders, such as depression, anxiety, and neurodegenerative diseases. Its unique structure, featuring a fluorine and trifluoromethyl group, enhances binding affinity and metabolic stability, making it valuable for designing selective and potent therapeutic agents. Additionally, it is utilized in the study of enzyme inhibition and receptor modulation, aiding in the discovery of novel treatments for various medical conditions.